Clinical Trial Update: Immunotherapy Master Trial for Advanced Cancers [Phase 2]

View source ↗

Summary

Phase 2 immunotherapy master trial for advanced cancers, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: UNICANCER | Conditions: Advanced / Metastatic Solid Tumors, Advanced Malignancy | Phase 2 | Status: NOT_YET_RECRUITING